Evotec SE Reports New 5.03% Stake by Michael Kaufman and Triton's Increased Holding to 9.97%

summarizeSummary

Evotec SE disclosed two significant ownership changes: Michael Kaufman's entities reported a new 5.03% stake, while Triton GP HoldCo SARL increased its holding to 9.97% from 9.16%.

check_boxKey Events · Ownership and Investor Activity · EVO

• Michael Kaufman's Entities Disclose New 5.03% Stake

  Michael Kaufman and associated entities, including MAK Capital Fund LP, reported a new aggregate holding of 5.03% of Evotec SE's voting rights, comprising 2.89% in direct shares and 2.14% through equity swaps. This represents a significant new institutional investment.

• Triton Increases Stake to 9.97%

  Triton GP HoldCo SARL, a private equity firm and existing major investor, increased its total holding in Evotec SE to 9.97% of voting rights, up from a previously reported 9.16%. The new filing indicates that the entire stake is now held as direct voting rights, suggesting a conversion of prior instrument holdings to direct shares, which demonstrates increased commitment.

auto_awesomeAnalysis · EVO · Life Sciences

These filings indicate strong institutional interest and conviction in Evotec SE. The emergence of Michael Kaufman's entities as a new 5.03% shareholder, combining direct shares and equity swaps, signals fresh investor confidence. Concurrently, Triton GP HoldCo SARL, an existing major investor, increased its stake to nearly 10% and appears to have converted previous instrument holdings into direct shares, further solidifying its commitment. Such significant accumulation by institutional investors can be a positive indicator for the company's future prospects.